Structures by: Porchia M.
Total: 18
C21H20ClCuN5P,C3H7NO
C21H20ClCuN5P,C3H7NO
Journal of medicinal chemistry (2013) 56, 18 7416-7430
a=8.343(5)Å b=15.605(5)Å c=20.060(5)Å
α=90.00° β=95.360(5)° γ=90.00°
C23H20BrCuN7P,2(C3H7NO)
C23H20BrCuN7P,2(C3H7NO)
Journal of medicinal chemistry (2013) 56, 18 7416-7430
a=39.605(8)Å b=14.234(3)Å c=11.434(2)Å
α=90.00° β=96.11(3)° γ=90.00°
C19H20NReS8
C19H20NReS8
Dalton transactions (Cambridge, England : 2003) (2005) 17 2866-2875
a=12.503(2)Å b=10.546(3)Å c=19.355(4)Å
α=90.00° β=90.00° γ=90.00°
C21H26NOS8Tc
C21H26NOS8Tc
Dalton transactions (Cambridge, England : 2003) (2005) 17 2866-2875
a=9.913(2)Å b=10.414(2)Å c=14.912(3)Å
α=109.94(3)° β=90.39(3)° γ=108.16(3)°
C7H8Cl3N4ORe
C7H8Cl3N4ORe
Inorganic Chemistry (2005) 44, 4045-4054
a=6.897(1)Å b=7.479(1)Å c=12.358(3)Å
α=103.67(3)° β=98.45(3)° γ=102.00(3)°
C14H19N4O5Re
C14H19N4O5Re
Inorganic Chemistry (2005) 44, 4045-4054
a=7.274(1)Å b=8.618(2)Å c=12.82(3)Å
α=89.91(3)° β=80.86(3)° γ=84.40(3)°
C8H7Cl2N4O3Re
C8H7Cl2N4O3Re
Inorganic Chemistry (2005) 44, 4045-4054
a=7.956(2)Å b=11.397(2)Å c=13.972(3)Å
α=91.70(3)° β=95.33(3)° γ=101.36(3)°
C40H42ClN2O4P2Re
C40H42ClN2O4P2Re
Inorganic Chemistry (2005) 44, 4766-4776
a=34.801(7)Å b=24.782(5)Å c=10.671(2)Å
α=90.00° β=103.84(3)° γ=90.00°
C36H42ClN2O4P2Re
C36H42ClN2O4P2Re
Inorganic Chemistry (2005) 44, 4766-4776
a=12.733(3)Å b=17.032(3)Å c=18.806(4)Å
α=107.01(3)° β=90.85(3)° γ=98.11(3)°
C36H39Cl2N2OP2Re
C36H39Cl2N2OP2Re
Inorganic Chemistry (2005) 44, 4766-4776
a=11.752(2)Å b=12.519(3)Å c=15.482(3)Å
α=75.97(3)° β=68.90(3)° γ=64.96(3)°
C34.5H35Cl4N2P2Re
C34.5H35Cl4N2P2Re
Inorganic Chemistry (2005) 44, 4766-4776
a=15.081(3)Å b=12.146(2)Å c=20.418(4)Å
α=90.00° β=107.05(3)° γ=90.00°
C34.5H35Cl4N2P2Tc
C34.5H35Cl4N2P2Tc
Inorganic Chemistry (2005) 44, 4766-4776
a=15.106(3)Å b=12.117(2)Å c=20.481(4)Å
α=90.00° β=107.25(3)° γ=90.00°
C30H29N4OPReS4
C30H29N4OPReS4
Inorganic Chemistry (2002) 41, 1591-1597
a=20.916(3)Å b=10.236(4)Å c=29.463(7)Å
α=90.00° β=92.33(2)° γ=90.00°
C38H33Cl2N2P2ReS2
C38H33Cl2N2P2ReS2
Inorganic Chemistry (2002) 41, 1591-1597
a=17.514(4)Å b=10.639(2)Å c=20.106(4)Å
α=90.00° β=102.29(3)° γ=90.00°
C29H31Cl4N2P2Tc
C29H31Cl4N2P2Tc
Inorganic Chemistry (2004) 43, 8617-8625
a=12.310(2)Å b=17.708(3)Å c=15.197(2)Å
α=90.00° β=109.65(1)° γ=90.00°
C30H31Cl2N2P2STc
C30H31Cl2N2P2STc
Inorganic Chemistry (2004) 43, 8617-8625
a=12.161(2)Å b=10.814(2)Å c=24.676(5)Å
α=90.00° β=101.93(3)° γ=90.00°
C29.5H33Cl2N2O0.5P2Re
C29.5H33Cl2N2O0.5P2Re
Inorganic Chemistry (2004) 43, 8617-8625
a=13.981(3)Å b=12.127(2)Å c=18.355(4)Å
α=90.00° β=95.31(3)° γ=90.00°
C24H21ReS8
C24H21ReS8
Dalton transactions (Cambridge, England : 2003) (2005) 17 2866-2875
a=5.9840(12)Å b=12.106(2)Å c=20.618(4)Å
α=101.61(3)° β=92.87(3)° γ=94.22(3)°